We shall never promote, condone, or celebrate violence or terrorism, but we will tell the truth even when that truth is ...

Four biosimilars for Stelara have launched in the United States this year following legal settlements with the reference ...

Special Needs Plans boosted a sluggish Medicare Advantage market during the annual enrollment period for 2025, a Modern ...

UnitedHealth Group is considered an undervalued stock with a strong economic moat. Analysts highlight its cost advantage, ...

UnitedHealth Group faced two new investigations from federal lawmakers. The first was a senator’s probe into its Medicare ...

Amedisys Inc. (Nasdaq: AMED) experienced growth in home health during the fourth quarter of 2024, despite incurring merger-related costs from its pending ...

Has Optum, Inc. gone too far in consolidating the health care industry, causing service quality and access to plummet?

Here are 10 updates on payer policies, executive moves and other news in February for ASC leaders to know: 1. A New York congressman is requesting public comment regarding patients' experiences with ...

Following complaints from constituents, a New York congressman is launching an examination of UnitedHealth Group's management of large physician groups in the state's Hudson Valley region. The inquiry ...

But it’s more than economics: The ongoing spread among cows has raised fears that bird flu could become an endemic pathogen ...

UnitedHealthCare is under investigation by the Department of Justice again for its Medicare Advantage billing practices. This is one of several legal battles and extraordinary mishaps the insurer has ...

The Oregon Senate Health Care Committee is scheduled on Tuesday to hear Senate Bill 951, which is intended to put guardrails ...